Article info
PDFHow to understand it
Hypersensitivity reactions to recombinant tissue plasminogen activator
- Correspondence to Dr Vafa Alakbarzade, Royal Cornwall Hospitals NHS Trust, Truro TR1 3LQ, UK; vafa.alakbarzade.10{at}ucl.ac.uk
Citation
Hypersensitivity reactions to recombinant tissue plasminogen activator
Publication history
- Accepted May 21, 2019
- First published July 4, 2019.
Online issue publication
July 02, 2020
Article Versions
- Previous version (14 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Critical upper airway obstruction in sporadic angioedema responding to C1-esterase inhibitor
- Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate
- A curious case of facial swelling in the night-time
- ‘Epinephrine-resistant’ angioedema
- A 22 year old man with acute genital oedema and a swollen ankle
- Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant: a bradykinin receptor antagonist
- Unilateral orolingual angioedema in a patient with sarcoidosis after intravenous thrombolysis due to acute stroke without improvement after treatment with icatibant
- Acquired C1-inhibitor deficiency presenting with nephrotic syndrome
- Investigating recurrent angio-oedema
- Life-threatening angio-oedema after the first dose of an ACE inhibitor—not an anaphylactic reaction